| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |